Remiges Ventures
Seattle, Washingtonremigesventures.com
Overview
Remiges Ventures is a cross-border venture capital firm that focuses on company creation and investments in early-stage drug discovery and development companies in the United States and Japan.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Kupando | Mar 2026 | Series A Extension | Lead |
| Endurance Bio Inc. | Dec 2025 | VC Round | Co-investor |
| Glycomine | Apr 2025 | Series C | - |
| Immunis, Inc. | Jan 2025 | Series A Extension | Co-investor |
| KisoJi Biotechnology | Oct 2024 | Series B | Co-investor |
Key People
Hiroshi Tamada
Chief Medical Officer, Scientific Advisor
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
